Newly emerging therapies for neonatal seizures.

Pressler, Ronit M; Mangum, B

Pressler, Ronit M; Mangum, B.

Affiliation

Pressler RM; Department of Clinical Neurophysiology, Great Ormond Street Hospital for Children NHS Trust, London WC1N 3JH, UK. ronit.pressler@gosh.nhs.uk

Semin Fetal Neonatal Med ; 18(4): 216-23, 2013 Aug.

Article in En | MEDLINE | ID: mdl-23688938

Subject(s)

Anticonvulsants/therapeutic use; Brain/drug effects; Child Development/drug effects; Neurogenesis/drug effects; Neurons/drug effects; Seizures/drug therapy; Animals; Anticonvulsants/adverse effects; Brain/pathology; Bumetanide/adverse effects; Bumetanide/therapeutic use; Epilepsy/drug therapy; Epilepsy/pathology; Fructose/adverse effects; Fructose/analogs & derivatives; Fructose/therapeutic use; Humans; Infant, Newborn; Levetiracetam; Neurons/pathology; Neuroprotective Agents/adverse effects; Neuroprotective Agents/therapeutic use; Piracetam/adverse effects; Piracetam/analogs & derivatives; Piracetam/therapeutic use; Seizures/pathology; Sodium Potassium Chloride Symporter Inhibitors/adverse effects; Sodium Potassium Chloride Symporter Inhibitors/therapeutic use; Topiramate

Key words

Antiepileptic drug treatment; Bumetanide; Drug trials; Levetiracetam; Newborn; Seizures neonatal; Topiramate

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Seizures / Brain / Child Development / Neurogenesis / Anticonvulsants / Neurons Type of study: Clinical_trials / Guideline Aspects: Ethics Limits: Animals / Humans / Newborn Language: En Journal: Semin Fetal Neonatal Med Year: 2013 Document type: Article

Fulltext

XML

PubMed Links

Search on Google